BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6731169)

  • 1. The short-term effects of reducing elevated blood pressure in elderly patients with propranolol and dyazide.
    Hamdy RC; Davies A; Arnold K; Tovey JD; Saimbi SS; Short MD; Exton-Smith AN
    Age Ageing; 1984 Mar; 13(2):83-8. PubMed ID: 6731169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new antihypertensive agent: Maxzide (75 mg triamterene/50 mg hydrochlorothiazide).
    Blume CD; Williams RL
    Am J Med; 1984 Nov; 77(5A):52-8. PubMed ID: 6388327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the anti-hypertensive effectiveness of two triameterene/hydrochlorothiazide combinations: Maxzide versus Dyazide.
    Casner PR; Dillon KR
    J Clin Pharmacol; 1990 Aug; 30(8):715-9. PubMed ID: 2401750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical experience with a new combination formulation of triamterene and hydrochlorothiazide (Maxzide) in patients with mild to moderate hypertension.
    Williams RL; Clark T; Blume CD
    Am J Med; 1984 Nov; 77(5A):62-6. PubMed ID: 6388328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Triamterene in the treatment of hypertension with hydrochlorothiazide and propranolol (author's transl)].
    Düsing R; Kramer HJ
    Dtsch Med Wochenschr; 1977 Oct; 102(43):1541-6. PubMed ID: 913294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy and bioequivalence of a brand-name and a generic triamterene-hydrochlorothiazide combination product.
    Sharoky M; Perkal M; Tabatznik B; Cane RC; Costello K; Goodwin P
    Clin Pharm; 1989 Jul; 8(7):496-500. PubMed ID: 2752698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive therapy with triamterene-hydrochlorothiazide vs amiloride-hydrochlorothiazide. Comparison of effects on urinary prostaglandin E2 excretion.
    Zawada ET
    Arch Intern Med; 1986 Jul; 146(7):1312-4. PubMed ID: 3521523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive effectiveness of very low doses of hydrochlorothiazide: results of the PHICOG Trial.
    Maroko PR; McDevitt JT; Fox MJ; Silber SA; Young MD; Beg M; Rockhold FW; Free SM; Herron JR; Gray JM
    Clin Ther; 1989; 11(1):94-119. PubMed ID: 2655909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Propranolol, triamteren and hydrochlorothiazide in fixed combinations in the treatment of hypertension (author's transl)].
    Herrmann JM; Hiemstra S; Hoenig B
    Dtsch Med Wochenschr; 1981 Sep; 106(36):1138-43. PubMed ID: 7261940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single-blind, randomized, cross-over study of angiotensin-converting enzyme inhibitor and triamterene and hydrochlorothiazide in the treatment of mild to moderate hypertension in the elderly.
    Woo J; Woo KS; Kin T; Vallance-Owen J
    Arch Intern Med; 1987 Aug; 147(8):1386-9. PubMed ID: 2820329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propranolol-hydrochlorothiazide combination in essential hypertension.
    Stevens JD; Mullane JF
    Clin Ther; 1982; 4(6):497-509. PubMed ID: 7046937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enalapril in essential hypertension.
    Herrera-Acosta J; Pérez-Grovas H; Fernández M; Arriaga J
    Drugs; 1985; 30 Suppl 1():35-46. PubMed ID: 2994986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in the ratio of plasma to intersitiial fluid volume during long-term antihypertensive therapy.
    Leth A; Ibsen H
    J Lab Clin Med; 1976 May; 87(5):781-91. PubMed ID: 1270888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Captopril versus hydrochlorothiazide/triamterene in mild-to-moderate hypertension in the elderly.
    Woo J; Woo KS; Vallance-Owen J
    Lancet; 1986 Oct; 2(8512):924. PubMed ID: 2876357
    [No Abstract]   [Full Text] [Related]  

  • 15. A comparison of a hydrochlorothiazide plus triamterene combination (Dyazide) and atenolol in the treatment of patients with mild hypertension: a multicentre study in general practice.
    Philip IG; Qureshi SM; Richards HH; Sharma SK; Wright FG; Young PH; Rowley-Jones D
    Br J Clin Pract; 1987 Oct; 41(10):947-53. PubMed ID: 3333144
    [No Abstract]   [Full Text] [Related]  

  • 16. A single-blind, comparative study of hydrochlorothiazide/amiloride ('Moduret' 25) and hydrochlorothiazide/triamterene ('dyazide') in elderly patients with congestive heart failure.
    Ghosh AK; Mankikar G; Strouthidis T; Windsor A; Long C; Glover DR
    Curr Med Res Opin; 1987; 10(9):573-9. PubMed ID: 3436153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrochlorothiazide-associated pulmonary edema.
    Anderson TJ; Berthiaume Y; Matheson D; Boiteau P
    Chest; 1989 Sep; 96(3):695-7. PubMed ID: 2766837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triamterene nephrolithiasis complicating dyazide therapy.
    Patel KM
    J Urol; 1981 Aug; 126(2):230. PubMed ID: 7265370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure lowering and potassium conservation by triamterene-hydrochlorothiazide and amiloride-hydrochlorothiazide in hypertension.
    Maxwell MH; Brachfeld J; Itskovitz H; Lunn JA; Moser M; Zawada ET
    Clin Pharmacol Ther; 1985 Jan; 37(1):61-5. PubMed ID: 3880686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Enalapril in the treatment of essential arterial hypertension].
    Pérez-Grovas H; Fernández M; Arriaga J; Herrera-Acosta J
    Arch Inst Cardiol Mex; 1986; 56(5):379-90. PubMed ID: 3026264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.